Cristina Robles-Gonzalez

UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Local field potential artifact detection: strategies for a challenge in adaptive deep brain stimulation.

Local field potential artifact detection: strategies for a challenge in adaptive deep brain stimulation.

Journal: Brain stimulation
Published: March 06, 2026

Neuroprotection in Parkinson Disease.

Neuroprotection in Parkinson Disease.

Journal: Neurology and therapy
Published: April 28, 2025

Improving recruitment and retention of people with Parkinson's disease to clinical studies: A scoping review.

Improving recruitment and retention of people with Parkinson's disease to clinical studies: A scoping review.

Journal: Journal of Parkinson's disease
Published: February 20, 2025

Progression of biological markers in spinocerebellar ataxia type 3: analysis of longitudinal data from the ESMI cohort.

Progression of biological markers in spinocerebellar ataxia type 3: analysis of longitudinal data from the ESMI cohort.

Journal: medRxiv : the preprint server for health sciences
Published: February 20, 2025

Progression of biological markers in spinocerebellar ataxia type 3: longitudinal analysis of prospective data from the ESMI cohort.

Progression of biological markers in spinocerebellar ataxia type 3: longitudinal analysis of prospective data from the ESMI cohort.

Journal: The Lancet regional health. Europe
Published: February 01, 2025

Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.

Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 06, 2024

Patient and Public Involvement and Engagement in the Development of a Platform Clinical Trial for Parkinson's Disease: An Evaluation Protocol.

Patient and Public Involvement and Engagement in the Development of a Platform Clinical Trial for Parkinson's Disease: An Evaluation Protocol.

Journal: Journal of Parkinson's disease
Published: May 03, 2024

Elevated Bile Acid 3β,5α,6β-Trihydroxycholanoyl Glycine in a Subset of Adult Ataxias Including Niemann-Pick Type C.

Elevated Bile Acid 3β,5α,6β-Trihydroxycholanoyl Glycine in a Subset of Adult Ataxias Including Niemann-Pick Type C.

Journal: Antioxidants (Basel, Switzerland)
Published: January 11, 2024

Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative.

Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative.

Journal: Journal of Parkinson's disease
Published: August 07, 2023

Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease Trials.

Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease Trials.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: June 22, 2023

Stage-dependent biomarker changes in spinocerebellar ataxia type 3.

Stage-dependent biomarker changes in spinocerebellar ataxia type 3.

Journal: medRxiv : the preprint server for health sciences
Published: May 10, 2023

Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3.

Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3.

Journal: Annals of neurology
Published: April 16, 2023
Showing 1-12 of 15

Last Updated: 09/26/2026